ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,824Medicare Part D Prescriptions Filled, Including Refills

Rank: 179 out of 1278

$546K Total Retail Price of All Prescriptions

Rank: 99 out of 1278

578 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 578 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 578 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 6,740 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LEVOTHYROXINE SODIUM 389 363 1 2
SIMVASTATIN 276 247 2 3
LOSARTAN POTASSIUM 247 224 3 19
AMLODIPINE BESYLATE 232 208 4 5
LISINOPRIL 229 209 5 1
HYDROCODONE-ACETAMINOPHEN 206 183 S3 6 7
METOPROLOL TARTRATE 184 160 7 9
METFORMIN HCL 182 153 8 4
PRAVASTATIN SODIUM 175 166 9 14
OMEPRAZOLE 157 139 10 6
ATORVASTATIN CALCIUM 157 141 10 15
ZOLPIDEM TARTRATE 155 117 12 16
SERTRALINE HCL 135 118 13 28
POTASSIUM CHLORIDE 134 123 14 21
ALENDRONATE SODIUM 118 109 15 18
LOSARTAN-HYDROCHLOROTHIAZIDE 114 101 16 75
FLUTICASONE PROPIONATE 110 100 17 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 90 18 30
LOVASTATIN 92 92 19 13
GLIMEPIRIDE 85 73 20 61
ATENOLOL 82 72 21 11
GABAPENTIN 80 69 22 12
CYMBALTA 79 66 23 67
CARISOPRODOL 76 44 R 24 51
METOPROLOL SUCCINATE 76 74 24 23
FLUOXETINE HCL 75 69 26 41
TRAZODONE HCL 71 60 27 38
DILTIAZEM ER 71 68 27 103
PANTOPRAZOLE SODIUM 70 66 29 34
DIOVAN 67 67 30 44
TRAMADOL HCL 66 39 31 25
CYCLOBENZAPRINE HCL 58 46 R 32 62
TRIAMTERENE-HCTZ 57 53 33 43
ADVAIR DISKUS 57 44 33 49
PROAIR HFA 55 49 35 26
CRESTOR 55 45 35 31
FUROSEMIDE 52 48 37 10
CITALOPRAM HBR 50 49 38 22
ACETAMINOPHEN-CODEINE 50 48 S3 38 98
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.